May 19, 2020

The 6 biggest pharmaceutical companies across the United States

maria collazo
3 min
The 6 biggest pharmaceutical companies across the United States

The biopharmaceutical sector is one of the most research and development (R&D)-intensive in the United States, with companies investing more than 10 times the amount of R&D per employee than all manufacturing industries overall, according to SelectUSA.

The Pharmaceutical Research and Manufacturers Association (PhRMA) also states that American pharmaceutical firms conduct the majority of the world’s research and development in pharma and hold the intellectual property rights on most new medicines.

RELATED TOPIC: How health companies can improve business by integrating a smarter cold chain

That being said, our sister publication Healthcare Global recently profiled the world’s largest pharmaceutical companies based on last month’s market capitalization numbers. Six of the ten were based in the U.S.

Here they are:

Abbott Laboratories | Chicago, Illinois

Market cap: US$72 billion

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of diversified health care products. More than 73,000 employees in over 150 countries are carrying out Abbott’s mission of advancing global health.

Abbot has revolutionized packaging and delivery to address regional needs and provide access to medicines in areas previously beyond the reach of health solutions.

Eli Lilly & Co. | Indianapolis, Indiana

Market cap: US$91.2 billion

Founded in 1876 by Colonel Eli Lilly, Eli Lilly & Co. now has over 41,000 employees worldwide with products marked in 120 countries.

Eli Lilly was one of the first companies to initiate a bonafide pharmaceutical research program, hiring a pharmaceutical chemist as its first scientist. The company was also one of the first to develop a method to mass-produce penicillin in the 1940s, the world’s first antibiotic, marking the beginning of a sustained effort to fight infectious diseases.

AbbVie Inc. | North Chicago, Illinois  

Market cap: US$107.64 billion

Based in Illinois, AbbVie is a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.

RELATED TOPIC: Google takes a step further into health care with new fitness tracker

Core areas of focus include immunology, kidney disease, liver disease, neuroscience, oncology and women’s health. AbbVie investigates both small and large molecule approaches, and internal research efforts are balanced with external collaborations across industry, academia and healthcare authorities.

Bristol-Myers Squibb Co. | New York City, New York

Market cap: US$108.67 billion

Bristol-Myers Squibb is a global biopharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. In the past seven years, the company has delivered 12 new medicines to patients.

Around the world, Bristol-Myers Squibb’s medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and rheumatoid arthritis.

Merck & Co. | Kenilworth, New Jersey

Market cap: US$165.73 billion

Merck has a long and rich history of working to improve people's health and well-being. Through the years, researchers have helped to find new ways to treat and prevent illness—from the discovery of vitamin B1, to the first measles vaccine, to cold remedies and antacids, to the first statins to treat high cholesterol.

RELATED TOPIC: Is your venture capital on the digital health bandwagon?

As of August 2014, Merck’s research and development effort has led to the U.S. FDA approval of 63 new drugs.

Pfizer | New York City, New York

Market cap: US$209.15 billion

Pfizer has a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas.

According to their site, “Through working in partnership with everyone from patients to health care providers and managed care organizations to world governments and non-governmental organizations, our goal is to ensure that people everywhere have access to innovative treatments and quality health care.”

Let's connect! Like us on Facebook and follow us on Twitter!

Click here to read the latest edition of Business Review USA!

Share article

Jun 13, 2021

Marketing matters: from IBM to Kyndryl

Kate Birch
5 min
Former CMO for IBM Americas Maria Bartolome Winans was recently named CMO for Kyndryl. Maria talks about her new role and her leadership style

Former Chief Marketing Officer for IBM Americas, and an IBM veteran of more than 25 years, Maria Bartolome Winans was recently named CMO for Kyndryl.

Prior to joining Kyndryl as Chief Marketing Officer, Maria had a 25-year career at IBM, most recently as the tech giant’s CMO where she oversaw all marketing professionals and activities across North America, Canada and Latin America. She has held senior global marketing positions in a variety of disciplines and business units across IBM, most notably strategic initiatives in Smarter Cities and Watson Customer Engagement, as well as leading teams in services, business analytics, and mobile and industry solutions. She is known for her work with teams to leverage data, analytics and cloud technologies to build deeper engagements with customers and partners.

With a passion for marketing, business and people, and a recognized expert in data-driven marketing and brand engagement, Maria talks to Business Chief about her new role, her leadership style and what success means to her.

You've recently moved from IBM to Kyndryl, joining as CMO. Tell us about this exciting new role?

I’m Chief Marketing Officer for Kyndryl, the independent company that will be created following the separation from IBM of its Managed Infrastructure Services business, expected to occur by the end of 2021. My role is to plan, develop, and execute Kyndryl's marketing and advertising initiatives. This includes building a company culture and brand identity on which we base our marketing and advertising strategy.

We have an amazing opportunity ahead at Kyndryl to create a company brand that will stand apart in the market by leading with our people first. Once we are an independent company, each Kyndryl employee will advance the vital systems that power human progress. Our people are devoted, restless, empathetic, and anticipatory – key qualities needed as we build on existing customer relationships and cultivate new ones. Our people are at the heart of this business and I am deeply hopeful and excited for our future.

What experiences have helped prepare you for this new opportunity?

I’ve had a very rich and diverse career history at IBM that has lasted 25+ years. I started out in sales but landed explored opportunities at IBM in different roles, business units, geographies, and functions. Marketing and business are my passions and I landed on Marketing because it allowed me to utilize both my left and right brain, bringing together art and science. In college, I was no tonly a business major, but an art major. I love marketing because I can leverage my extensive knowledge of business, while also being able to think openly and creatively.

The opportunities I was given during my time at IBM and my natural curiosity have led me to the path I’m on now and there’s no better next career step than a once-in-a-lifetime-opportunity to help launch a company. The core of my role at Kyndryl is to create a culture centered on our people and growing up in my career at IBM has allowed me to see first-hand how to prioritize people and ensure they are at the heart of progress in everything Kyndryl will do.

How would you describe your leadership style?

I believe that people aren't your greatest assets, they are your only assets. My platform and background for leadership has always been grounded in authenticity to who I am and centered on diversity and inclusion. I immigrated to the US from Chile when I was 10 years old and so I know the power and beauty that comes from leaning into what makes you different from other people, and that's what I want every person in my marketing organization to feel – the value in bringing their most authentic self to work every day. The way our employees feel when they show up for themselves authentically is how they will also show up for our customers, and strong relationships drive growth.

I think this is especially true in light of a world forever changed by the pandemic. Living through such an unprecedented time has reinforced that we are all humans. We can't lead or care for one another without empathy and I think leaders everywhere have been reminded of this.

What’s the best leadership advice you’ve received?

When I was growing up as an immigrant in North Carolina, I often wanted to be just like everyone else. But my mother always told me: Be unique, be memorable – you have an authentic view and experience of the world that no one else will ever have, so don't try to be anyone else but you.

What does success look like to you?

I think the concept of success is multi-faceted. From a career perspective, being in a job where you're respected and appreciated, and where you can see how your contributions are providing value by motivating your teams to be better – that's success! From a personal perspective, there is no greater accomplishment than investing in the next generation. I love mentoring younger professionals – they are the future. I want my legacy as a leader to include providing value in work culture, but also in leaving a personal impact on the lives of professionals who will carry the workforce forward. Finding a position in life with a job and company that offers me a chance at all of that is what success looks like to me.

What advice would you give to your younger self just starting out in the industry?

I've always been a naturally curious person and it's easy for me to over-commit to projects that pique my interest. I've learned over years of practice how to manage that, so to my younger self I’d say… prioritize the things that are most important, and then become amazing at those things.

Share article